Drugmakers Reveal List Prices Online After Pressure From Trump - (Bloomberg via NewsPoints Desk)

  • Drugmakers are detailing list prices for drugs online in an effort to avert pressure from US President Donald Trump for greater disclosures, Bloomberg reported Thursday.

  • In response to a Trump administration proposal that would require price disclosures for certain advertisements, the Pharmaceutical Research and Manufacturers of America issued guidance urging members to use television ads to direct patients to view pricing information online.

  • Amgen and Pfizer have created new digital hubs providing patients with pricing information for multiple drugs, while AbbVie, AstraZeneca, Bristol-Myers Squibb and Sanofi have added list prices to product-specific websites for treatments including Eliquis, Humira, Symbicort and Toujeo.

  • "If your aim is transparency, those prices need to be upfront and not require additional action from the patient," remarked Connecture senior vice president Jim Yocum, adding "when you click through a website, that scale and reach is diluted down to nothing."

  • "Providing the greater context on the website, where we can give list price but also expected out-of-pocket cost dependent on what kind of insurance you have, is much more meaningful to patients” than putting prices in TV ads," countered Mark Taylor, spokesperson for Eli Lilly, which has provided drug pricing information on websites for four products, including Verzenio.

  • Meanwhile, Health and Human Services Secretary Alex Azar has praised Johnson & Johnson for becoming the first drugmaker to put list prices directly in television ads in February.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.